Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
1,268
1,268 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- COM701Phase 21 trial
Compugen Ltd · Ovarian Cancer, Ovarian Cancer Recurrent
- CORT125236NenocorilantPhase 21 trial
Corcept Therapeutics · Neoplasms
- CP-383Phase 21 trial
Tasca Therapeutics · Solid Tumor Malignancies, Colorectal Carcinoma, Small Cell Lung Cancer ( SCLC )
- CPT-11Phase 21 trial
Zhejiang Doer Biologics Co., Ltd. · Gastrointestinal Cancer
- CR-001Phase 21 trial
Crescent Biopharma, Inc. · Locally Advanced / Metastatic Solid Tumors
- CR-002Phase 21 trial
Crescent Biopharma, Inc. · Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M), Gastric/GEJ, Biliary Tract Cancer (BTC)
- CR6086vorbipiprantPhase 21 trial
Rottapharm Biotech · Refractory Metastatic Colorectal Cancer, Solid Tumor, Metastatic Microsatellite-stable Colorectal Cancer
- CRG-150Phase 21 trial
CoRegen, Inc. · HR-positive, HER2-negative Breast Cancer, TNBC - Triple-Negative Breast Cancer, Prostate Cancer
- CRN09682Phase 21 trial
Crinetics Pharmaceuticals Inc. · SST2-positive Neuroendocrine Neoplasms, Neuroendocrine Tumors, Neuroendocrine Neoplasm
- CS2009Phase 21 trial
CStone Pharmaceuticals · Advanced Solid Tumors
- CS5006Phase 21 trial
CStone Pharmaceuticals · Advanced Solid Tumors
- CT041Phase 21 trial
CARsgen Therapeutics Co., Ltd. · Gastric Cancer, Pancreatic Cancer
- CT3001Phase 21 trial
Crossignal Therapeutics, Inc. · Solid Tumor, Adult, Colorectal Cancer, Pancreatic Ductal Adenocarcinoma
- CTS3497Phase 21 trial
CytosinLab Therapeutics Co., Ltd. · Solid Tumor, Lymphoma
- CTX-471Phase 21 trial
Compass Therapeutics · Neuroendocrine Neoplasm, Neuroendocrine Carcinomas, Neuroendocrine Tumors
- CYT-0851Phase 21 trial
Cyteir Therapeutics, Inc. · Malignancy, Non-hodgkin Lymphoma, Multiple Myeloma
- DA-4505Phase 21 trial
Dong-A ST Co., Ltd. · Locally Advanced or Metastatic Solid Tumors
- DanvatirsenAZD9150Phase 21 trial
AstraZeneca · Non-Small Cell Lung Cancer
- DAT-2645Phase 21 trial
Danatlas Pharmaceuticals Co., Ltd · Advanced or Metastatic Ovarian Cancer
- DB-1310Phase 21 trial
DualityBio Inc. · Advanced Solid Tumor
- DB-1324Phase 21 trial
DualityBio Inc. · Gastrointestinal Cancer
- DB-1419Phase 21 trial
DualityBio Inc. · Solid Tumor, Adult
- DC05F01Phase 21 trial
Heronova Pharmaceuticals · Solid Tumors, Ovarian Cancer, Small Cell Lung Cancer
- DCC-3009Phase 21 trial
Deciphera Pharmaceuticals, LLC · Gastrointestinal Stromal Tumor (GIST)
- Debio 4228Phase 21 trial
Debiopharm International SA · Prostate Cancer
- Decoy20Phase 21 trial
Indaptus Therapeutics, Inc · Solid Tumor, Adult, HCC - Hepatocellular Carcinoma, CRC (Colorectal Cancer)
- DES-1357Phase 21 trial
D. E. Shaw Research, LLC · Metastatic Colorectal Cancer (CRC)
- DF1001Phase 21 trial
Dragonfly Therapeutics · Solid Tumor, Adult
- DF9001Phase 21 trial
Dragonfly Therapeutics · Solid Tumor, Adult
- DJI136Phase 21 trial
Novartis · Extensive-stage Small Cell Lung Cancer (ES-SCLC)
- DKN-01LY2812176Phase 21 trial
Leap Therapeutics, Inc. · Colorectal Cancer, Colorectal Adenocarcinoma, Colo-rectal Cancer
- DM002Phase 21 trial
Xadcera Biopharmaceutical (Suzhou) Co., Ltd. · Ovarian Neoplasms, Prostatic Neoplasms, Endometrial Neoplasms
- DM005Phase 21 trial
Doma Biopharmaceutical(Suzhou)Co., Ltd. · Carcinoma, Non-Small-Cell Lung, Squamous Cell Carcinoma of Head and Neck, Solid Carcinoma
- DocetetaxelPhase 21 trial
Merck & Co. · Carcinoma, Non-Small-Cell Lung
- DR30206Phase 21 trial
Zhejiang Doer Biologics Co., Ltd. · Gastrointestinal Cancer
- DS-1103aPhase 21 trial
Daiichi Sankyo · Solid Tumor, Locally Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer
- DT-7012Phase 21 trial
Domain Therapeutics Australia Pty Ltd · Advanced Solid Tumors
- DXC006Phase 21 trial
Hangzhou DAC Biotechnology Co., Ltd. · Small Cell Lung Cancer
- DYP688Phase 21 trial
Novartis · Metastatic Uveal Melanoma
- E7090Phase 21 trial
Eisai · Cholangiocarcinoma
- E7386Phase 21 trial
Eisai · Endometrial Neoplasms, Neoplasms, Carcinoma, Hepatocellular
- E7389-LFPhase 21 trial
Eisai · Solid Neoplasms
- EB-701CA9-NKPhase 21 trial
Beijing Biotech · Advanced or Metastatic Clear Cell Renal Cell Carcinoma
- ECI830Phase 21 trial
Novartis · Advanced HR+/HER2- Breast Cancer, Advanced CCNE1-amplified Solid Tumors, Extensive-stage Small Cell Lung Cancer
- EF-009Phase 21 trial
Everfront Biotech Co., Ltd. · Pancreatic Cancer
- EfineptakinNT-I7, rhIL-7-hyFcPhase 21 trial
NeoImmuneTech · Any Advanced Solid Tumors, Triple Negative Breast Cancer, Non Small Cell Lung Cancer
- EG-70Phase 21 trial
enGene, Inc. · Superficial Bladder Cancer, Non-muscle Invasive Bladder Cancer With Carcinoma in Situ, Non-muscle Invasive Bladder Cancer
- EGL-001Phase 21 trial
Egle Therapeutics · Solid Tumor, Adult
- EIK1004-001IMP1707-001Phase 21 trial
Eikon Therapeutics · Advanced Solid Tumors
- EIK1005Phase 21 trial
Eikon Therapeutics · Advanced Solid Tumors, MSI-H or dMMR Advanced Solid Tumors, MSI-H/dMMR Gastric Cancer
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.